Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05226455
What this trial is testing

Venetoclax in Patients With MDS or AML in Relapse After AHSCT

Who this might be right for
MDSAML
Groupe Francophone des Myelodysplasies 55
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Early research (Phase 1)Active Not RecruitingNCT01840566
What this trial is testing

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 17
Very early researchUnknownNCT04439721
What this trial is testing

ΓδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse

Who this might be right for
Leukemia, B-cell
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 5
Early research (Phase 1)Study completedNCT05472428
What this trial is testing

Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

Who this might be right for
Stem Cell Infusion
Vinmec Research Institute of Stem Cell and Gene Technology 11
Testing effectiveness (Phase 2)UnknownNCT04551456
What this trial is testing

WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Navy General Hospital, Beijing 300
Testing effectiveness (Phase 2)Ended earlyNCT03059355
What this trial is testing

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Who this might be right for
Endothelial DysfunctionMetabolic SyndromeChronic Inflammation
Joshua M Hare 14
Early research (Phase 1)WithdrawnNCT01336478
What this trial is testing

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells
Imperial College London
Not applicableNo Longer AvailableNCT00759018
What this trial is testing

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

Who this might be right for
Graft vs Host DiseaseGraft-Versus-Host Disease
Mesoblast, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Large-scale testing (Phase 3)Study completedNCT01233960
What this trial is testing

Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 73
Testing effectiveness (Phase 2)Looking for participantsNCT06491043
What this trial is testing

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells

Who this might be right for
Chronic Obstructive Pulmonary Disease
Meribank Biotech Co., Ltd. 90
Testing effectiveness (Phase 2)Ended earlyNCT00003552
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Not applicableUnknownNCT01506258
What this trial is testing

Autologous Stem Cells in Newborns With Oxygen Deprivation

Who this might be right for
Apgar; 0-3 at 1 MinuteMetabolic AcidosisHypoxia, Brain+1 more
Hospital Universitario Dr. Jose E. Gonzalez 20
Testing effectiveness (Phase 2)Looking for participantsNCT05943067
What this trial is testing

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

Who this might be right for
Hematologic Malignancy
University Hospital Tuebingen 60
Early research (Phase 1)UnknownNCT05155657
What this trial is testing

Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

Who this might be right for
Alcoholic Cirrhosis
Yantai Yuhuangding Hospital 36
Testing effectiveness (Phase 2)UnknownNCT00986557
What this trial is testing

T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseNonneoplastic Condition
University Hospital Birmingham 78
Next Page
30